Keywords
CML
coexistence
How to Cite
Abstract
We present a male patient with first diagnosis of Philadelphia chromosome negative myeloproliferative neoplasm (MPN), with no response to treatment and worsening of his symptoms. In further studies, stands out the coexisting diagnosis of chronic myeloid leukemia (CML) and afterwards the patient develops anemia requiring transfusions. The characteristics of this case represented a diagnostic and therapeutic challenge for the treating medical team and led to new re-assessments of the patient's situation, as well as consults with experts in the field in order to search for better strategies. A bibliographical review of the subject is described below.
References
Boddu P, Chihara D, Masarova L y col. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms. Ann Hematol;. 2018;97(11):2071-2080.
Kandarpa M, Wi Y, Robinson D, Burke P, Chinnaiyan A, Talpaz M. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis. Am J Hematol. 2017;92:555-561.
Montivero A. JAK 2 y BCR-ABL. ¿Son siempre mutuamente excluyentes? Hematología. 2021;25:147-150.
Yi JH, Kim HR. Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib. Blood Res. 2019;54(1): 77-79.
Hussein K, Bock O, Seegers A et al. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Blood. 2007;109:4106-4107.
Eliacik E, Isik A, Aydin C y col. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia. Hematology. 2015;20(7):392-6.
Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2021;96:145-162.
Polverelli N, Farina M, D’Adda M y col. How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation. Cells. 2022;11(3),553.
Salit R, Scott B, Stevens E y col. Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis. Bone Marrow Transplant. 2020; 5:70-76.
Robin M, Zine M, Chevret S y col. The impact of splenectomy in myelofibrosis patients before allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:958-964.
Helbig G, Wieczorkiewicz-Kabut A, Markiewicz M y col. Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis. Med Oncol. 2019 Jan 8;36(2):16.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar